Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Isolation Market

Cell Isolation Market Size

  • Report ID: GMI6469
  • Published Date: Aug 2023
  • Report Format: PDF

Cell Isolation Market Size

Cell Isolation Market size was valued to be USD 5.2 billion in 2022 and is expected to reach USD 16.1 billion in 2032 with a CAGR of 12.1% from 2023 to 2032.The market is primarily driven by several key factors such as the rising prevalence of chronic and infectious diseases such as cancer and COVID-19, rising government support for cell-based research, growing emphasis on customized therapy and technical improvements.

 

Cell isolation and separation-related technological advances are anticipated to accelerate the market's growth. Moreover, rising research and development processes in the pharmaceutical and biotechnology sectors and the introduction of various advanced equipment and methodologies is expected to expand the market progress.

 

Cell isolation is the process of separating specific cells from a mixture of different cell types in a biological sample. It is aimed to extract the desired cells while maintaining their viability, integrity, and functional properties through various techniques. It is crucial for a number of applications, including the design and development of biologics, the production of therapeutic proteins, in-vitro diagnostics, and other applications in research, such as the collection of circulating tumour cells in the blood, the molecular analysis of particular cell populations, the isolation of immune cells from peripheral blood and the preparation of blood samples that have been separated from plasma.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market for cell isolation size was valued to be USD 5.2 billion in 2022 and is expected to reach over USD 16 billion by 2032, driven by the rising prevalence of chronic and infectious diseases such as cancer and COVID-19, government support for cell-based research, and growing emphasis on customized therapy.

Due to increasing incidence of chronic and infectious diseases such as cancer, the human cells segment held the largest market share in 2022 and is expected to grow at CAGR of 12.2% during 2023 to 2032.

North American cell isolation market accounted for revenue share of 42.8% in 2022 and will continue to grow through 2032, due to a considerable increase in patient pool of chronic diseases, and government funding for cancer R&D in pharmaceutical & biotechnological sector.

Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Corning Inc., STEMCELL Technologies Inc., Invent Biotechnologies, Qiagen NV, Alfa Laval AB, Sartorius AG, and Bio-Techne Corporation.

Cell Isolation Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 632
  • Countries covered: 20
  • Pages: 370
 Download Free Sample